Omalizumab (Xolair®) increased the time to first exacerbation in patients with moderate-to-severe asthma compared with placebo

被引：0
|
作者：
O'Brien, JA
Fox, H
Thirlwell, J
机构：
[1] City Pk Med Ctr, Cape Town, South Africa
[2] Novartis Res Ctr, Horsham, W Sussex, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2001年 / 107卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
358
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [21] Experience with omalizumab in patients with moderate and severe asthma
    Cacacho, Ana Lucia Figueredo
    Gracia, Jose Angel Carretero
    Alonso, Dinora Polanco
    Manes, Clara Vinado
    Paz, Carolina Panadero
    Saez, Sandra Garcia
    Gomara, Sara
    Leon, Erica
    Robles, Ana Lilian Simon
    Valles, Enrique Chacon
    Dronda, Salvador Bello
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [22] Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma
    Cheng, Lu
    Yang, Tianrui
    Ma, Xiang
    Han, Yuling
    Wang, Yongtai
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 370 - 382
  • [23] The Effect Of Omalizumab On Lung Function In Adolescents With Moderate-To-Severe Allergic Asthma
    Busse, W. W.
    Humbert, M.
    Stephenson, P.
    Iqbal, A.
    Trzaskoma, B. L.
    Conde, L. Garcia
    Hepburn, J.
    Ortiz, B.
    Kianifard, F.
    Holgate, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] Omalizumab is an effective add-on therapy in moderate-to-severe allergic asthma
    不详
    Drugs & Therapy Perspectives, 2005, 21 (7) : 1 - 5
  • [25] Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma
    Ohta, Ken
    Miyamoto, Terumasa
    Amagasaki, Taro
    Yamamoto, Manabu
    RESPIROLOGY, 2009, 14 (08) : 1156 - 1165
  • [26] Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review
    Storms, William
    Bowdish, Matthew S.
    Farrar, Judith R.
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (02) : 172 - 177
  • [27] Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis
    Fu, Zhuo
    Xu, Yongsheng
    Cai, Chunquan
    JOURNAL OF ASTHMA, 2021, 58 (10) : 1350 - 1358
  • [28] EFFECT OF OMALIZUMAB ON SEASONAL EXACERBATIONS IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ALLERGIC ASTHMA
    Corren, J.
    Casale, T.
    Haselkorn, T.
    Yang, M.
    Iqbal, A.
    Ortiz, B.
    Busse, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S6 - S7
  • [29] Omalizumab Improves Asthma Symptoms, Asthma Control, and Health-Related Quality of Life in Chinese Patients With Moderate-to-Severe Asthma
    Li, Jing
    Kang, Jian
    Wang, Changzheng
    Yang, Jing
    Humphries, Michael
    Greenberg, Steven
    Zhong, Nanshan
    CHEST, 2016, 149 (04) : 6A - 6A
  • [30] Baseline Blood Eosinophils and Reduction of Asthma Exacerbations By Omalizumab in Children with Moderate-to-Severe Allergic Asthma
    Szefler, Stanley J.
    Casale, Thomas B.
    Rosen, Karin
    Trzaskoma, Benjamin L.
    Haselkorn, Tmirah
    Ortiz, Benjamin
    Busse, William
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB83 - AB83
12345